Sameer Jhavar

hi

[Sameer Jhavar @sameerjhavar]

@VedangMurthy @TataMemorial @ACTREC_TMC @docpriyamvada @ASCO_pubs @APCCC_Lugano Congratulations👏

[Sameer Jhavar @sameerjhavar]

9 coronavirus charts everyone should see https://t.co/kn4Iz1RW4d via @voxdotcom

[Sameer Jhavar @sameerjhavar]

@_ShankarSiva @gerryhanna @PeterMacRadOnc @SimonLo21054188 @DrAlexLouie @MichaelStaehler @uretericbud @cpeedell @declangmurphy @nickbrookMD @uroegg Thanks Shankar.

[Sameer Jhavar @sameerjhavar]

@Prof_Nick_James @nickva1 @DrSpratticus @Prof_IanD @MRCCTU @MaxParmarMRCUCL @PSUrol Brilliant. Would love to participate and accrue. Let me know how and when. Thanks

[Sameer Jhavar @sameerjhavar]

Top 10 ASTRO Abstracts 2018 https://t.co/ndBA14al8s via @CleClinicMD

[Sameer Jhavar @sameerjhavar]

https://t.co/ASfB2DdA4s

[Paul A. Bergl @PaulBerglMD]

I forced a bot to read 1000 #internalmedicine personal statements & write its own. The syntax is a little off, but this bot has the template down! (Credit to @KeatonPatti's shtick.)

#meded #match2019

Disclosures: I read every PS in detail, and I love interviewing applicants.

[Sameer Jhavar @sameerjhavar]

https://t.co/dGL3aLN4hw

[Sameer Jhavar @sameerjhavar]

https://t.co/A0z0lihutp

[The ASCO Post @ASCOPost]

CONVERT Trial: Concurrent Chemoradiotherapy to Treat Elderly Patients With Limited-Stage SCLC https://t.co/PIS6C82u3f #LCSM #oncology

[Sameer Jhavar @sameerjhavar]

https://t.co/42lDOCe7Vo

[Sameer Jhavar @sameerjhavar]

https://t.co/zAbtfnTsac

[Sameer Jhavar @sameerjhavar]

https://t.co/FVUXkg5W5W

[Sameer Jhavar @sameerjhavar]

https://t.co/UKwH9UlYSr

[Elekta @Elekta]

Great day for oligometastatic disease! In a 24 hrs, 3 randomized trials demonstrate substantially improved survival in oligometastatic patients treated w/ consolidative RT. Lung: https://t.co/LxIEa1c8WX prostate: https://t.co/Qz5xl3kZVo all tumor types: https://t.co/KwjK1e7arh

[Sameer Jhavar @sameerjhavar]

https://t.co/nAaoMIbaLE

[Joshua Meeks @JoshMeeks]

Exciting data from our NRG colleagues. Sets the tone for S1806. Congrats on a very nice trial.
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Canc.. https://t.co/uzx2M1YFgB

[Drew Moghanaki @DrewMoghanaki]

This, is a true golden nugget. @SFreedlandMD

[The Lancet Oncology @TheLancetOncol]

Now in our Nov issue: previously presented at #ESMO2018 @myESMO: #Nivolumab plus #ipilimumab or nivolumab alone versus ipilimumab alone in advanced #melanoma (#CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial https://t.co/5T8POrSXkg